Deutsche Bank Cuts Informa (INF) Price Target to GBX 930

Share on StockTwits

Informa (LON:INF) had its target price reduced by Deutsche Bank from GBX 955 ($12.48) to GBX 930 ($12.15) in a research report released on Tuesday morning. They currently have a buy rating on the stock.

A number of other research firms have also recently commented on INF. Shore Capital reaffirmed a buy rating on shares of Informa in a research report on Monday, August 13th. Morgan Stanley cut shares of Informa to an equal weight rating and set a GBX 850 ($11.11) price objective for the company. in a research report on Thursday, August 16th. Peel Hunt reaffirmed a hold rating on shares of Informa in a research report on Wednesday, September 5th. Citigroup raised shares of Informa to a buy rating in a research report on Friday, September 28th. Finally, Barclays reduced their price objective on shares of Informa from GBX 940 ($12.28) to GBX 885 ($11.56) and set an overweight rating for the company in a research report on Friday, September 28th. Four research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The company presently has an average rating of Buy and a consensus price target of GBX 870.67 ($11.38).

INF stock opened at GBX 651.80 ($8.52) on Tuesday. Informa has a one year low of GBX 624.50 ($8.16) and a one year high of GBX 773 ($10.10).

Informa Company Profile

Informa plc engages in business intelligence, academic publishing, and knowledge and events businesses worldwide. The company operates through Academic Publishing, Business Intelligence, Global Exhibitions, and Knowledge & Networking segments. The Academic Publishing segment publishes academic books and journals in print and digital formats for university libraries and departments, specialist research institutions, and individuals in the areas of humanities and social sciences, science, technology, and medicine.

Further Reading: What is a stock buyback?

Analyst Recommendations for Informa (LON:INF)

Receive News & Ratings for Informa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Informa and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.